MASSDEVICE ON CALL —Plaintiff Linda Gross took the stand this week in a bellwether trial against Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s transvaginal mesh implants.

Gross made the case that she, a former nurse, had done her homework before deciding to accept treatment with the Ethicon’s Prolift device, which is used to treat pelvic organ prolapse, but that Ethicon and J&J had failed to provide information about all of the risks.

Gross claims the implant left her with severe chronic pain that prevents her from working or even sitting. During her testimony, most of which she gave while standing as the pain kept her from sitting comfortably for more than 20 minutes, she explained that she was taking about 20 drugs to help cope with the pain, Mesh Medical Device News Desk reported.

Decisions made in this trial, which is taking place in New Jersey and expected to take about 2 months, may trickle down to similar lawsuits against C.R. Bard (NYSE:BCR), Endo Pharmaceuticals Holdings (NSDQ:ENDP) and Boston Scientific (NYSE:BSX).

 Consumer Reports reviews cancer tests

Consumer reports, a long-time reviewer of consumer products such as cars and appliances, turned their attention to cancer screening, deeming only cervical cancer, colon cancer and breast cancer screening, but only for certain patient groups.
Read more

 New thrombus concerns with TAVI have researchers concerned
Cardiologists found 3 suspected cases of thrombosis believed to be related to transcatheter aortic valve implantation, a risk that doctors don’t generally associate with TAVI devices.
 
Read more

 Magnets may be the key to growing realistic tissue samples
Magnets may help petri-dish organisms break into 3D, and some researchers are already using "magnetic levitation" to grow 3-dimensional cell cultures that could have applications in in research or in clinical use.  
Read more